Denise M. Oleary - 01 May 2024 Form 4 Insider Report for Medtronic plc (MDT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 May 2024, 13:11:17 UTC
Prior SEC filing
01 May 2024
Next SEC filing
06 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas L. Osteraas, attorney-in-fact

Key filing fact

Denise M. Oleary filed Form 4 for Medtronic plc (MDT) on 03 May 2024.

Key facts

  • This page summarizes Denise M. Oleary's Form 4 filing for Medtronic plc (MDT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 May 2024, 13:11.

Change

  • Previous filing in this sequence was filed on 01 May 2024.
  • Current net transaction value: -$15,531.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Tax liability

Transaction value
$15,531
Shares
-192
Change %
-0.25%
Price
$80.89
Shares after
77,057
Date
01 May 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .